bufotenin has been researched along with 1-(1-naphthyl)piperazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
| Grol, CJ; Schmidt, AW; Sprouse, JS; Vermeulen, ES; Wikström, HV | 1 |
1 review(s) available for bufotenin and 1-(1-naphthyl)piperazine
| Article | Year |
|---|---|
Central serotonin receptors as targets for drug research.
Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin | 1987 |
2 other study(ies) available for bufotenin and 1-(1-naphthyl)piperazine
| Article | Year |
|---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site.
Topics: Binding Sites; Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Receptors, Serotonin; Serotonin Receptor Agonists; Tetrahydronaphthalenes; Tryptamines | 2003 |